Based on the latest data from Aug 1, 2026, MTD's PEG ratio sits at 2.59. This metric combines a PE of 31.85 with an earnings growth rate of 12.3%. Relative to the 5.01 average from the past 4 quarters, the PEG ratio fell by 48%.
Looking at the past ten years, MTD's PEG ratio has settled around 4.25 on average. At 2.59, today's PEG ratio sits 39% lower than its historical average. Within the past ten years, the Dec 2017 quarter saw the highest PEG reading at 47.08. At 0.71, the Dec 2018 quarter represented the lowest PEG ratio in this timeframe.
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 8.94 | 33.06 | 3.7% |
| 2024 | 2.37 | 30.09 | 12.7% |
| 2023 | N/A | 33.6 | -6.9% |
| 2022 | 2.23 | 37.26 | 16.7% |
| 2021 | 1.61 | 51.04 | 31.7% |
| 2020 | 4.3 | 45.15 | 10.5% |
| 2019 | 2.82 | 34.73 | 12.3% |
| 2018 | 0.71 | 27.82 | 39.1% |
| 2017 | 47.08 | 42.37 | 0.9% |
| 2016 | 2.12 | 28.89 | 13.6% |
| 2015 | 2.99 | 26.6 | 8.9% |
| 2014 | 1.77 | 25.83 | 14.6% |
| 2013 | 2.61 | 23.74 | 9.1% |
| 2012 | 1.89 | 20.63 | 10.9% |
| 2011 | 0.83 | 17.48 | 21.1% |
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Jun 2026 | 2.34 | 28.73 | 12.3% |
| Mar 2026 | 4.84 | 29.55 | 6.1% |
| Dec 2025 | 8.94 | 33.06 | 3.7% |
| Sep 2025 | 3.92 | 30.55 | 7.8% |
| Jun 2025 | 3.53 | 29.67 | 8.4% |
| Mar 2025 | 2.41 | 29.35 | 12.2% |
| Dec 2024 | 2.37 | 30.09 | 12.7% |
| Sep 2024 | N/A | 40.24 | -5.5% |
| Jun 2024 | N/A | 38.27 | -8.8% |
| Mar 2024 | N/A | 37.14 | -9.7% |
| Dec 2023 | N/A | 33.6 | -6.9% |
| Sep 2023 | 4.07 | 28.09 | 6.9% |
| Jun 2023 | 2.85 | 32.76 | 11.5% |
| Mar 2023 | 2.55 | 38.56 | 15.1% |
| Dec 2022 | 2.23 | 37.26 | 16.7% |
Measured against past performance, MTD's PEG ratio comes in under the 3, 5 and 10-year averages.
Mettler-Toledo International's PEG of 2.59 is higher than the Healthcare sector and the industry average. In comparison with the Healthcare sector average of 0.56, Mettler-Toledo International's PEG is 363% higher.
Among its peers, MTD has a PEG ratio below stocks TMO and XYL, while higher than DHR's and BIO's.
| Stock name | PEG ratio | Market cap |
|---|---|---|
| BIO Bio-Rad Laboratories Inc - Class A | 0.53 | $8.89B |
| DHR Danaher Corp | 1.79 | $138.82B |
| MTD Mettler-Toledo International Inc | 2.61 | $28.55B |
| XYL Xylem Inc | 3.09 | $27.61B |
| TMO Thermo Fisher Scientific Inc | 4.12 | $212.69B |
| WAT Waters Corp | N/A | $36.78B |
| BRKR Bruker Corp | N/A | $9.68B |
| HBIO Harvard Bioscience Inc | N/A | $27.67M |
MTD has a PEG ratio of 2.59, per Aug 1, 2026 data.
Across the past 3 years, MTD's PEG ratio has centered around 4.05.
Across the past 5 years, MTD's PEG ratio has centered around 3.02.
The Dec 2017 quarter marked the ten years high at 47.08 for MTD's PEG ratio.
MTD currently has a PEG ratio 39% below its 10-year average.
When a company's earnings growth lags its valuation, the PEG ratio tends to be elevated - as seen with MTD's 2.59 reading.
The PEG ratio derives from taking PE and dividing by the rate at which earnings are growing (YoY TTM). As of Aug 1, 2026, Mettler-Toledo International carries a PE ratio of 31.85. Earnings grew at 12.3% over the TTM period ending Jun 2026. Applying the formula, this yields a PEG ratio of 2.59. PEG RATIO(2.59) = PE RATIO(31.85) / EPS GROWTH(12.3%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.